A different proliferative effect of leptin in breast cancer cells involves the leptin mediated upregulation of human telomerase reverse transcriptase (hTERT) activity and expression in a dose-dependent fashion also involving STAT3 phosphorylation (71). Here, LEP is linked to breast carcinoma.